Trade Summary

1 week ago, Heerma Peter, serving as Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX), sold 4,980 shares at $40.00 per share, for a total transaction value of $199,200.00. Following this transaction, Heerma Peter now holds 113,013 shares of TVTX.

This sale represents a 4.00% decrease in Heerma Peter's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, December 24, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 5 days after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.